ADAMTS2 promotes gastric cancer progression and is associated with epithelial-mesenchymal transition and the tumour microenvironment

Authors: Ding, Tao; Dai, Lijun; Chen, Peiqiang; Ge, Wei; Yu, Huajiong; Qi, Xiao; Zhu, Zijie; Bie, Yaqin

Source journal: Translational oncology (2026-11-16)

DOI: 10.1016/j.tranon.2026.103118

Abstract

Gastric cancer progression is closely linked to epithelial-mesenchymal transition (EMT), extracellular matrix (ECM) remodelling and changes in the tumour microenvironment, yet biomarkers capturing these coordinated processes remain limited. We integrated transcriptomic datasets, machine-learning-based prioritisation, multi-cohort validation, single-cell analysis and functional assays to investigate ADAMTS2. ADAMTS2 was consistently upregulated in gastric cancer tissues and cell lines and discriminated tumour from normal tissue with an area under the receiver operating characteristic curve of 0.945. Higher ADAMTS2 expression was associated with advanced clinicopathological features and poorer survival. Genome-wide co-expression and weighted gene co-expression network analyses identified an ADAMTS2-associated module strongly linked to EMT, TGF-beta activity and invasion. These associations were consistently reproduced across three independent gastric cancer cohorts, with increasing ADAMTS2 expression accompanied by enhanced mesenchymal and invasion-related programmes and an opposing epithelial pattern. Single-cell analysis localised ADAMTS2 predominantly to fibroblast and myofibroblast populations. Across three cohorts, ADAMTS2 correlated positively with stromal and immune scores and inversely with tumour purity, while multi-algorithm deconvolution revealed concordant associations with fibroblast/CAF, macrophage and endothelial-cell infiltration. In AGS and HGC-27 cells, ADAMTS2 knockdown suppressed proliferation, colony formation, migration and invasion, increased E-cadherin, and decreased N-cadherin and vimentin. Stable knockdown also reduced xenograft growth. Collectively, these findings identify ADAMTS2 as a candidate biomarker connecting an EMT- and ECM-remodelling transcriptional programme with a fibroblast-rich, immune-remodelled microenvironment in gastric cancer.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.